Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$4K Buy
+100
New +$4.48K ﹤0.01% 9583
2014
Q2
Sell
-300
Closed -$13K 10373
2014
Q1
$13K Buy
+300
New +$14.3K ﹤0.01% 8588
2013
Q4
Sell
-800
Closed -$27K 10352
2013
Q3
$27K Sell
800
-4,300
-84% -$140K ﹤0.01% 7664
2013
Q2
$146K Buy
+5,100
New +$149K ﹤0.01% 5437

Other funds holding ALKS

UBS's ALKS Position: Q3 2014 in Review

UBS reduced its Alkermes (ALKS) stake by 25% in Q3 2014, selling an estimated $1.78M and leaving 118,317 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

UBS first reported a position in ALKS in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.95M in Q2 2014. 204 funds tracked by Wall St. Rank hold ALKS as of Q3 2014.

  • UBS held 118,317 shares of Alkermes worth $5.07M as of Q3 2014.
  • UBS sold 39,629 Alkermes shares in Q3 2014, an estimated $1.78M.
  • Alkermes made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2017 holding.
  • UBS first reported a position in Alkermes in Q2 2013 and has held it in 6 quarters since.
  • UBS's Alkermes position peaked at $7.95M in Q2 2014.
  • 204 funds tracked by Wall St. Rank held Alkermes as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.